Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France's Minvasys releases Nile stent on market:

This article was originally published in Clinica

Executive Summary

Minvasys, a French manufacturer and marketer of coronary balloons, stents and the proprietary vascular access system SuperKetch, has launched Nile, an intracoronary stent designed for easy and secured access to bifurcated arteries for the treatment of plaque. The product, described as a smart and simple device, has a specific delivery system for bifurcation lesions. It allows for the treatment of both the main and side branches simultaneously or sequentially. It was CE-marked in March 2004. The product addresses the 20% of the population with coronary diseases that have lesions at bifurcations, says Minvasys, which is based in Gennevilliers, in the Paris area. Minvasys has been in operation for one year, having been formed in May 2003.

You may also be interested in...



US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.

Topics

UsernamePublicRestriction

Register

MT058546

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel